Lutzke BS - Search Results

1

Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.

Hall ED, Andrus PK, Smith SL, Fleck TJ, Scherch HM, Lutzke BS, Sawada GA, Althaus JS, Vonvoigtlander PF, Padbury GE, Larson PG, Palmer JR, Bundy GL. Hall ED, et al. Among authors: lutzke bs. J Pharmacol Exp Ther. 1997 May;281(2):895-904. J Pharmacol Exp Ther. 1997. PMID: 9152399

2

Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.

Hall ED, Andrus PK, Smith SL, Oostveen JA, Scherch HM, Lutzke BS, Raub TJ, Sawada GA, Palmer JR, Banitt LS, Tustin JS, Belonga KL, Ayer DE, Bundy GL. Hall ED, et al. Among authors: lutzke bs. Acta Neurochir Suppl. 1996;66:107-13. doi: 10.1007/978-3-7091-9465-2_19. Acta Neurochir Suppl. 1996. PMID: 8780807 Review.

3

Increased lipophilicity and subsequent cell partitioning decrease passive transcellular diffusion of novel, highly lipophilic antioxidants.

Sawada GA, Barsuhn CL, Lutzke BS, Houghton ME, Padbury GE, Ho NF, Raub TJ. Sawada GA, et al. Among authors: lutzke bs. J Pharmacol Exp Ther. 1999 Mar;288(3):1317-26. J Pharmacol Exp Ther. 1999. PMID: 10027873

4

Novel, highly lipophilic antioxidants readily diffuse across the blood-brain barrier and access intracellular sites.

Sawada GA, Williams LR, Lutzke BS, Raub TJ. Sawada GA, et al. Among authors: lutzke bs. J Pharmacol Exp Ther. 1999 Mar;288(3):1327-33. J Pharmacol Exp Ther. 1999. PMID: 10027874

5

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.

Merchant KM, Gill GS, Harris DW, Huff RM, Eaton MJ, Lookingland K, Lutzke BS, Mccall RB, Piercey MF, Schreur PJ, Sethy VH, Smith MW, Svensson KA, Tang AH, Vonvoigtlander PF, Tenbrink RE. Merchant KM, et al. Among authors: lutzke bs. J Pharmacol Exp Ther. 1996 Dec;279(3):1392-403. J Pharmacol Exp Ther. 1996. PMID: 8968364

6

HPLC-chemiluminescence and thermospray LC/MS study of hydroperoxides generated from phosphatidylcholine.

Zhang JR, Cazers AR, Lutzke BS, Hall ED. Zhang JR, et al. Among authors: lutzke bs. Free Radic Biol Med. 1995 Jan;18(1):1-10. doi: 10.1016/0891-5849(94)e0090-6. Free Radic Biol Med. 1995. PMID: 7896162

7

Kinetic evaluation of lipophilic inhibitors of lipid peroxidation in DLPC liposomes.

Horan KL, Lutzke BS, Cazers AR, McCall JM, Epps DE. Horan KL, et al. Among authors: lutzke bs. Free Radic Biol Med. 1994 Dec;17(6):587-96. doi: 10.1016/0891-5849(94)90098-1. Free Radic Biol Med. 1994. PMID: 7867975

8

Tirilazad mesylate protects stored erythrocytes against osmotic fragility.

Epps DE, Knechtel TJ, Bacznskyj O, Decker D, Guido DM, Buxser SE, Mathews WR, Buffenbarger SL, Lutzke BS, McCall JM, et al. Epps DE, et al. Among authors: lutzke bs. Chem Phys Lipids. 1994 Dec;74(2):163-74. doi: 10.1016/0009-3084(94)90057-4. Chem Phys Lipids. 1994. PMID: 7859342

9

(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.

TenBrink RE, Bergh CL, Duncan JN, Harris DW, Huff RM, Lahti RA, Lawson CF, Lutzke BS, Martin IJ, Rees SA, Schlachter SK, Sih JC, Smith MW. TenBrink RE, et al. Among authors: lutzke bs. J Med Chem. 1996 Jun 21;39(13):2435-7. doi: 10.1021/jm960084f. J Med Chem. 1996. PMID: 8691438 No abstract available.

10

Spontaneous aggregation and cytotoxicity of the beta-amyloid Abeta1-40: a kinetic model.

Taylor BM, Sarver RW, Fici G, Poorman RA, Lutzke BS, Molinari A, Kawabe T, Kappenman K, Buhl AE, Epps DE. Taylor BM, et al. Among authors: lutzke bs. J Protein Chem. 2003 Jan;22(1):31-40. doi: 10.1023/a:1023063626770. J Protein Chem. 2003. PMID: 12739896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page